Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Diers

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Cancer Research|March 14, 2001
Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrowL R Belur, D Boelk-Galvan, M D Diers, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemiaColin L Sweeney, Miechaleen D Diers, Joel L Frandsen, et al.
Plant Disease|June 10, 2020
Evaluation of Foliar Diseases for Soybean Entries in the Pan-African Trials in Malawi and ZambiaChristabell Nachilima, Godfree Chigeza, Mwila Chibanda, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 29, 2005
Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activityLalitha R Belur, Rohaizah I James, Chad May, et al.
American Journal of Hematology|June 18, 2011
Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotypeStephen M Wiesner, Jennifer L Geurts, Miechaleen D Diers, et al.
Blood|November 9, 2006
Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant miceAndrew Kim, Kelly Morgan, Diane E Hasz, et al.
Nature Biomedical Engineering|December 13, 2023
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repairBeau R Webber, Matthew J Johnson, Joseph G Skeate, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Blood|October 16, 2014
NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemiaZohar Sachs, Rebecca S LaRue, Hanh T Nguyen, et al.
Nature Communications|December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Cancer Research|March 14, 2001
Methotrexate accumulates to similar levels in animals transplanted with normal versus drug-resistant transgenic marrowL R Belur, D Boelk-Galvan, M D Diers, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Methotrexate exacerbates tumor progression in a murine model of chronic myeloid leukemiaColin L Sweeney, Miechaleen D Diers, Joel L Frandsen, et al.
Plant Disease|June 10, 2020
Evaluation of Foliar Diseases for Soybean Entries in the Pan-African Trials in Malawi and ZambiaChristabell Nachilima, Godfree Chigeza, Mwila Chibanda, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 29, 2005
Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activityLalitha R Belur, Rohaizah I James, Chad May, et al.
American Journal of Hematology|June 18, 2011
Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotypeStephen M Wiesner, Jennifer L Geurts, Miechaleen D Diers, et al.
Blood|November 9, 2006
Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant miceAndrew Kim, Kelly Morgan, Diane E Hasz, et al.
Nature Biomedical Engineering|December 13, 2023
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repairBeau R Webber, Matthew J Johnson, Joseph G Skeate, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Blood|October 16, 2014
NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemiaZohar Sachs, Rebecca S LaRue, Hanh T Nguyen, et al.
Nature Communications|December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Pageof 11